Neurocognitive Safety
Research activity is centred on the long-term effects of repeated exposure to gadolinium-based contrast agents in neurologically normal adults, with attention to changes in motor function and cognitive function over time.
- Motor performance
- Cognitive outcomes
- Long-term neurologic monitoring
The trial landscape includes comparison with a matched non-exposed control population to evaluate functional changes associated with repeated contrast-enhanced imaging.
Radiology and Contrast Imaging
The sponsor’s clinical interest includes contrast-enhanced MRI and the safety profile of repeated use of linear and macrocyclic gadolinium agents in imaging practice.
- Magnetic resonance imaging
- Contrast agent exposure
- Gadolinium retention concerns
Its funded research is aligned with evaluating whether repeated imaging-related exposure is associated with measurable functional effects in adults.
Adult Neurology
Current activity focuses on adult participants without known neurologic disease, with interest in subtle changes affecting neurologic function, coordination, and everyday cognition.
- Neurologically normal adults
- Functional neurologic assessment
- Age-related cognitive tracking
This places emphasis on detecting small but clinically relevant shifts in neurologic performance associated with repeated diagnostic exposure.
Multinational Clinical Research
The sponsor supports a multicountry research setting with collaborating sites across Europe, reflecting interest in coordinated clinical evaluation across diverse populations.
- Cross-border site collaboration
- Participant follow-up
- Comparative observational analysis
Site participation extends the assessment of imaging-related safety outcomes across several active trial locations.
